However, in the present validation study, we confirmed that a simple model consisting of two clinical variables (history of stroke and diabetes treated with insulin) and NT-proBNP level successfully predicted the risk of stroke in HFrEF patients without AF (Structured Graphical Abstract). The gene discussed is INS; the disease is diabetes mellitus.